
Vorasidenib analyses featured at SNO 2026 examine longer-term outcomes and seizure burden in IDH-mutant glioma, underscoring the importance of sustained monitoring during oral therapy.
Pharmacy Practice in Focus: Oncology
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Klara Kim, PharmD, will present her encore abstract, “Clinical Manifestations of Acute and Chronic Graft-vs-Host Disease With Posttransplant Cyclophosphamide in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation,” at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20.






